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Novel implications of Lingo-1 and its signaling partners in 
the Dorsolateral Prefrontal Cortex in Schizophrenia 
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Enright1,2 
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Myelination and neurite outgrowth both occur during brain development and their disturbance has 
been previously implicated in the pathophysiology of schizophrenia. Leucine-rich repeat and 
immunoglobulin domain-containing protein (Lingo-1), is a potent negative regulator of axonal 
myelination and neurite extension. Since co-factors of Lingo-1 signaling (Nogo receptor (NgR), 
With No Lysine (K) (WNK1) and Myelin transcription factor 1 (Myt1)) have been previously 
implicated in the genetics of schizophrenia, we explored for the first time the role of Lingo-1 
signaling pathways in this disorder. Lingo-1 protein, together with its co-receptor and cofactor 
proteins NgR, TNF receptor orphan Y (TROY), p75, WNK1 and Myt1, have never been explored 
in the pathogenesis of schizophrenia. 
Methods 
We examined protein levels of Lingo-1, NgR, TROY, p75, WNK1 and Myt1 within the post-
mortem dorsolateral prefrontal cortex (DLPFC), a brain region highly disrupted in schizophrenia 
pathophysiology; from 37 schizophrenia patients versus 37 matched controls from the NSWBrain 
Bank Network. 
Results 
Lingo-1 protein expression was found to be significantly increased by 12% (p=0.006) in the 
DLPFC of schizophrenia subjects. A significant 19.5% increase in Lingo-1 expression was found 
in schizophrenia males compared to control males (p<0.001). 
In contrast to Lingo-1, NgR protein expression was significantly decreased by 16% (p<0.001). 
Interestingly, neither the third receptor in this trimolecular receptor complex p75, nor its homolog 
TROY, showed any significant difference in levels of protein expression in schizophrenia subjects 
compared to controls (p=0.146 and p=0.500 respectively). Analysis of WNK1 revealed no 
statistically significant difference in expression in the DLPFC between schizophrenia and control 
subjects (p=0.864).However a significant 11.5% increase in Myt1 expression was observed in 
schizophrenia compared to control groups (p=0.023). 
Conclusions 
This is the first study to examine the expression profile of Lingo-1 and its signaling partner 
proteins in schizophrenia, identifying alterations of these pathways in the DLPFC from 
schizophrenia patients. Further analysis will be required to characterize these interactions at a 
molecular and cell specific level. However, this innovative finding provides the first foundation 
for a new avenue in the development of future therapies for schizophrenia. 
	   	  
